Why These 24 Stocks Are Skyrocketing
One of the strongest stock market anomalies is the momentum effect, which is the tendency of recent past winners to outperform the recent past losers.
Chimerix Inc (CMRX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 8,800,000 | $30,624,000 | 0.4% | |
| 2. | Deerfield Management James E. Flynn | 3,771,342 | $13,124,270 | 0.24% | |
| 3. | Millennium Management Israel Englander | 2,557,530 | $8,900,204 | +7% | 0% |
| 4. | Armistice Capital Steven Boyd | 2,236,000 | $7,781,280 | +2% | 0.1% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 2,213,940 | $7,704,511 | +1319% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.96 | 17,295 | Director | 100,000 | 2023-11-17 | Filing | |
| $0.92 | 2,705 | Director | 82,705 | 2023-11-10 | Filing | |
| $0.98 | 20,000 | Director | 80,000 | 2023-09-25 | Filing | |
| $1.14 | 51,700 | Officer | 357,015 | 2023-05-18 | Filing | |
| $1.12 | 75,015 | Officer, Director | 87,000 | 2023-05-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.50 | 3,065 | 152,875 | 2025-02-13 | Filing | ||
| $4.52 | 7,370 | 609,603 | 2025-02-13 | Filing | ||
| $4.52 | 1,600 | 213,596 | 2025-02-13 | Filing | ||
| $4.53 | 300 | 148,987 | 2025-02-13 | Filing | ||
| $4.51 | 2,260 | 172,977 | 2025-02-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,044,877 | $14,076,172 | 0% | |
| 2. | 3,050,000 | $10,614,000 | 5.42% | |
| 3. | 2,820,792 | $9,816,356 | 1.42% | |
| 4. | 1,065,914 | $3,709,381 | 0.08% | |
| 5. | 836,696 | $2,912,606 | 0% |
News See All
Chimerix, Inc. (NASDAQ:CMRX) Q3 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen and welcome to the Chimerix Third Quarter 2024 Earnings Conference Call.
Chimerix, Inc. (NASDAQ:CMRX) Q2 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. And welcome to the Chimerix Second Quarter 2024 Earnings Conference Call.
Chimerix, Inc. (NASDAQ:CMRX) Q1 2024 Earnings Call Transcript
Chimerix, Inc. misses on earnings expectations. Reported EPS is $-0.25 EPS, expectations were $-0.21. Chimerix, Inc.
Chimerix, Inc. (NASDAQ:CMRX) Q4 2023 Earnings Call Transcript
Chimerix, Inc. beats earnings expectations. Reported EPS is $-0.2, expectations were $-0.23.
Chimerix, Inc. (NASDAQ:CMRX) Q3 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Chimerix Third Quarter 2023 Earnings Conference Call.
12 Best Penny Stocks to Buy Under $1
Investors are optimistic as we move into the third quarter earnings season.
5 Most Undervalued Penny Stocks To Invest In
Broadcasting and media company Sirius XM Holdings Inc. (NASDAQ:SIRI) ranks 4th in our list of the most undervalued penny stocks to buy according to hedge funds.
5 Best Quality Penny Stocks to Buy
Chimerix, Inc. (NASDAQ:CMRX) is working on treatments for fatal diseases. Chimerix, Inc.
Chimerix, Inc. (NASDAQ:CMRX) Q2 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Chimerix Second Quarter 2023 Earnings Conference Call.
Billionaire Hedge Funds
